Cetera Investment Advisers Trans Medics Group, Inc. Transaction History
Cetera Investment Advisers
- $42.2 Billion
- Q2 2024
A detailed history of Cetera Investment Advisers transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 8,705 shares of TMDX stock, worth $751,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,705
Previous 11,106
21.62%
Holding current value
$751,676
Previous $821,000
59.68%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding TMDX
# of Institutions
368Shares Held
29.7MCall Options Held
395KPut Options Held
152K-
Black Rock Inc. New York, NY2.65MShares$228 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$218 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.49MShares$128 Million2.41% of portfolio
-
Invesco Ltd. Atlanta, GA1.36MShares$118 Million0.04% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.15MShares$98.9 Million3.04% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.75B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...